EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #63
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature. Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #Methoxyacetylfentanyl
Wilde, M; Pichini, S; Pacifici, R; Tagliabracci, A; Busardò, FP; Auwärter, V; Solimini, R. Metabolic pathways and potencies of new fentanyl analogs. Front. Pharmacol., 5 Apr 2019, 10 (238). 1.5 MB. https://doi.org/10.3389/fphar.2019.00238 #Methoxyacetylfentanyl
Armenian, P; Vo, KT; Barr-Walker, J; Lynch, KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology, 1 May 2018, 134, 121–132. 847 kB. https://doi.org/10.1016/j.neuropharm.2017.10.016 #Methoxyacetylfentanyl
Sasaki, R; Ishizaki, N; Ando, T; Hino, C. Analytical profile of methoxyacetylfentanyl. JCCL, 1 Oct 2017, (57), 127–132. 9.8 MB. #methoxyacetylfentanyl Japanese, English abstract MS,NMR,IR,UV
Anon. INCB: Fentanyl-related substances with no known legitimate use. 24 Jun 2018, n/a. 189 kB. #67
POE-F · Phenoxyethyl-norfentanyl
4′-MeO-AF · p-Methoxy-acetylfentanyl
3-Methyl phenoxy acetylfentanil
O-(2-Ethylbutanoyl)lysergol
Methoxyacetylfentanyl-d5-Ph